The total number of N-SSATS SA treatment program cases included in the current analyses per county per year was calculated in order to examine whether SA treatment program density was related to Medicaid acceptance.
NSDUH estimates annualizing 2003 and 2004 were assigned to N-SSATS data for those respective years.
N-SSATS data are cross-sectional and cannot investigate causality.
Indeed, our multilevel analysis using the 2003 N-SSATS data substantiated the importance of a number of structural and treatment focus/service characteristics of treatment facilities--including their focus on general health care, substance abuse, or mental health; affiliation with a hospital; the provision of hospital in-patient treatment and supportive services; licensing and accreditation; ownership and financing--on their likelihood of adopting naltrexone.
Further, although the N-SSATS data are rich in terms of the substance abuse treatment facility characteristics, they do not include measures of staff education, training, tenure, and treatment philosophies, which have been shown by other research to be important to pharmaceutical adoption.
Characteristics of the TCOM programs were compared against those responding to N-SSATS in 2005 (U.
Over-sampling for "mixed" outpatient programs in the Great Lakes (56 percent N-SSATS, 70 percent TCOM) and private-nonprofits in the Southeast (52 percent N-SSATS, 100 percent TCOM) could account for some of the regional differences reported above.